Navigating Neurological Autoimmunity in Cancer Treatment

This chapter explores the intricate interplay between checkpoint inhibitors and neurological autoimmunity in cancer therapy. It examines the rise in immune checkpoint inhibitors, their unexpected neurological effects, and the complexity of treatment approaches for patients with pre-existing conditions. The discussion highlights the need for personalized treatment, ongoing research, and the anticipation of advancements that could enhance patient care.